Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is EZETIMIBE USP, with a corresponding US DMF Number 25653.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 01, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II